Download

Download Full Text (212 KB)

Description

First described in 1877 by Jonathan Hutchinson, sarcoidosis affects approximately 150,000 to 200,000 patients in America and is characterized by the presence of non-caseating granulomas. The exact cause remains poorly understood. In the United States, risk is greater in African-American patients and in greater predominance in women compared to men. It can affect any organ system, though it most frequently begins in the lungs. Cutaneous sarcoidosis can be seen in approximately one third of cases. Cutaneous forms can be nonspecific as in erythema nodosum, or specific with granulomatous infiltration. Cutaneous sarcoidosis is a particularly challenging diagnosis, as a single patient can have a variety of lesions in terms of appearance, each of which may appear resemble countless other pathologies including; lichen planus, psoriasis, fungal infection, or cutaneous T-cell lymphoma

Publication Date

5-9-2025

Disciplines

Internal Medicine

Comments

2025 Research Day Corewell Health West, Grand Rapids, MI, May 9, 2025. Abstract 1717

The Masquerade or What's in This Skin; A Case of Cutaneous Sarcoidosis

Share

COinS